0001209191-22-022570.txt : 20220404 0001209191-22-022570.hdr.sgml : 20220404 20220404172948 ACCESSION NUMBER: 0001209191-22-022570 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PASSERI DANIEL R CENTRAL INDEX KEY: 0001190121 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 22803952 MAIL ADDRESS: STREET 1: C/O CURIS INC STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-31 0 0001645460 Cue Biopharma, Inc. CUE 0001190121 PASSERI DANIEL R C/O CUE BIOPHARMA, INC. 21 ERIE STREET CAMBRIDGE MA 02139 1 1 0 0 CHIEF EXECUTIVE OFFICER Common Stock 2022-03-31 4 M 0 75000 A 173700 D Common Stock 2022-03-31 4 F 0 32122 4.88 D 141578 D Common Stock 2022-03-31 5 G 0 E 10000 0.00 D 131578 D Restricted Stock Units 2022-03-31 4 M 0 75000 0.00 D Common Stock 75000 0 D Represents shares of common stock received upon vesting of a restricted stock unit award. Each restricted stock unit award represents a contingent right to receive one share of common stock. One half of the Restricted Stock Units vested on September 30, 2021 and the balance vested on March 31, 2022. /s/ Daniel Passeri by Colin Sandercock, attorney-in-fact 2022-04-04